Literature DB >> 28218756

Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation.

J Zou1, R Romee2, M Slade2, D Phelan3, J Keller2, T Mohanakumar4, B J Grossman1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28218756      PMCID： PMC6298599          DOI： 10.1038/bmt.2017.7

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

2.  Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.

Authors:  Stefan O Ciurea; Peter F Thall; Denái R Milton; Titus H Barnes; Piyanuch Kongtim; Yudith Carmazzi; Asdrúbal A López; Dianne Y Yap; Uday Popat; Gabriela Rondon; Benjamin Lichtiger; Fleur Aung; Vahid Afshar-Kharghan; Qing Ma; Marcelo Fernández-Viña; Richard E Champlin; Kai Cao
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-15       Impact factor: 5.742

3.  The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.

Authors:  Stephen Spellman; Robert Bray; Sandra Rosen-Bronson; Michael Haagenson; John Klein; Susan Flesch; Cynthia Vierra-Green; Claudio Anasetti
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

4.  T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.

Authors:  Asad Bashey; Xu Zhang; Connie A Sizemore; Karen Manion; Stacey Brown; H Kent Holland; Lawrence E Morris; Scott R Solomon
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

5.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

6.  Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

Authors:  Douglas E Gladstone; Andrea A Zachary; Ephraim J Fuchs; Leo Luznik; Yvette L Kasamon; Karen E King; Robert A Brodsky; Richard J Jones; Mary S Leffell
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-22       Impact factor: 5.742

7.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Brent R Logan; Zhiwei Wang; Edwin P Alyea; Matt E Kalaycio; Richard T Maziarz; Joseph H Antin; Robert J Soiffer; Daniel J Weisdorf; J Douglas Rizzo; Mary M Horowitz; Wael Saber
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

8.  High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Authors:  Stefan O Ciurea; Marcos de Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

9.  Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review.

Authors:  Armin Rashidi; John F DiPersio; Peter Westervelt; Ravi Vij; Mark A Schroeder; Amanda F Cashen; Todd A Fehniger; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-17       Impact factor: 5.742

10.  Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.

Authors:  Ying-Jun Chang; Xiang-Yu Zhao; Lan-Ping Xu; Xiao-Hui Zhang; Yu Wang; Wei Han; Huan Chen; Feng-Rong Wang; Xiao-Dong Mo; Yuan-Yuan Zhang; Ming-Rui Huo; Xiao-Su Zhao; Kong Y; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388
View more
  2 in total

1.  Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Jun Zou; Tao Wang; Meilun He; Yung-Tsi Bolon; Shahinaz M Gadalla; Steven G E Marsh; Michelle Kuxhausen; Robert Peter Gale; Akshay Sharma; Amer Assal; Tim Prestidge; Mahmoud Aljurf; Jan Cerny; Sophie Paczesny; Stephen R Spellman; Stephanie J Lee; Stefan O Ciurea
Journal:  Transplant Cell Ther       Date:  2021-11-11

Review 2.  Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.

Authors:  Rachel E Crossland; Francesca Perutelli; Katarzyna Bogunia-Kubik; Nuala Mooney; Nina Milutin Gašperov; Maja Pučić-Baković; Hildegard Greinix; Daniela Weber; Ernst Holler; Dražen Pulanić; Daniel Wolff; Anne M Dickinson; Marit Inngjerdingen; Magdalena Grce
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.